Lung Cancers Today路 @Lung_Cancers 路 X路路 1 day agoScore70
Body
馃珌 Coming up at #ESMO26: The second Presidential Symposium kicks off at 4:30 CET with the presentation of Krascendo 1 by @FSkoulidis of @UTMDAnderson!
鉃★笍 Stay tuned for our coverage and find more #ESMO2026 news here: https://buff.ly/6YOVI22.
#NSCLC #lcsm
34 views 路 1 like 路 0 reposts 路 0 replies
Conference abstracts
Krascendo 3: A randomised, phase III trial in progress of divarasib vs immunotherapy or observation in patients with resected, stage II-IIIB, KRAS G12C+ non-small cell lung cancer
https://esmocongress.esmo.orgSource: Lung Cancers Today 路 x.com
